semaglutide step 5 IMPACT OF ONCE-WEEKLY SUBCUTANEOUS 2.4 MG ON METABOLIC SYNDROME IN THE 2-YEAR, RANDOMIZED CONTROLLED TRIAL PDF) Two-year effects of semaglutide

= 8.0) in the placebo group

It is essential to understand that Semaglutide / Cyanocobalamin Injection is available via patient-specific prescription from our 503A compounding pharmacy, which means it is prepared specifically for individual patients based on a physicians determination that the medication is necessary to treat the patient

Semaglutide treatment commenced at 0.25 mg per week for the initial 4 weeks using a pre-filled pen injector, with a fixed-dose escalation every 4 weeks until reaching the maintenance dose of 2.4 mg by week 16 (lower maintenance doses allowed if 2.4 mg was intolerable for participants)

UTIs did not emerge as a statistically significant side effect in any of these trials